Streetwise Reports Examines Why This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers SAN FRANCISCO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (VIV:TSX.V), a biotech company focused on science-based, natural health products for livestock, companion animals and humans, is making...